Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a network of laboratories and company-owned patient service centers. It offers a range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, clinical trial testing, life insurer services and various healthcare information technology and diagnostic products. Quest Diagnostics provides its services to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories and governmental agencies, among others. The company, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Secaucus, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Quest Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Quest Diagnostics Inc Company Overview
- Quest Diagnostics Inc Company Snapshot
- Quest Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Quest Diagnostics Inc - Pipeline Analysis Overview
- Business Description
- Quest Diagnostics Inc - Key Facts
- Quest Diagnostics Inc - Major Products and Services
- Quest Diagnostics Inc Pipeline Products by Development Stage
- Quest Diagnostics Inc Pipeline Products Overview
- AAVrh74 ELISA Companion Diagnostic Assay - Duchenne Muscular Dystrophy (DMD)
- AAVrh74 ELISA Companion Diagnostic Assay - Duchenne Muscular Dystrophy (DMD) Product Overview
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD)
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD) Product Overview
- AI-Enabled Computational Pathology - Solid Tumor
- AI-Enabled Computational Pathology - Solid Tumor Product Overview
- Biomarker Test - Genetic Disorders
- Biomarker Test - Genetic Disorders Product Overview
- Bromotyrosine Test
- Bromotyrosine Test Product Overview
- Cardio IQ KIF6 Genotype Test
- Cardio IQ KIF6 Genotype Test Product Overview
- Cardiovascular Mortality Prediction Test
- Cardiovascular Mortality Prediction Test Product Overview
- Diagnostic Assay - Colorectal Cancer
- Diagnostic Assay - Colorectal Cancer Product Overview
- Genotyping Assay - Cystic Fibrosis
- Genotyping Assay - Cystic Fibrosis Product Overview
- Genotyping Assay - Fragile X Syndrome
- Genotyping Assay - Fragile X Syndrome Product Overview
- HDL Function Test
- HDL Function Test Product Overview
- LungDx
- LungDx Product Overview
- MRD Test - Breast Cancer
- MRD Test - Breast Cancer Product Overview
- MRD Test - Colorectal Cancer
- MRD Test - Colorectal Cancer Product Overview
- MRD Test - Lung Cancer
- MRD Test - Lung Cancer Product Overview
- Urine Biomarker Test - Prostate Cancer
- Urine Biomarker Test - Prostate Cancer Product Overview
- VeraMarker BCR Test - LDT
- VeraMarker BCR Test - LDT Product Overview
- ViroSeq HCV Assay
- ViroSeq HCV Assay Product Overview
- Quest Diagnostics Inc - Key Competitors
- Quest Diagnostics Inc - Key Employees
- Quest Diagnostics Inc - Key Employee Biographies
- Quest Diagnostics Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Quest Diagnostics Inc, Recent Developments
- Apr 02, 2024: Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
- Feb 13, 2024: Quest Diagnostics Debuts MelaNodal Predict Test, Personalizing Melanoma Risk Prediction to Help Patients Forgo Invasive Surgery
- Jan 09, 2024: Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
- Dec 19, 2023: Quest Diagnostics Launches New 88-Compound Novel Psychoactive Substance Test Panel
- Dec 14, 2023: Haystack Oncology and Rutgers Cancer Institute Collaborate to use Haystack MRD in Clinical Study of Early-Stage Triple-Negative Breast Cancer
- Dec 07, 2023: Quest Diagnostics and CDC Expand Public Health Research Collaboration to Better Understand Hepatitis C Burden in the United States
- Aug 30, 2023: Quest Diagnostics Granted FDA Breakthrough Designation for Its Adeno-Associated Virus (AAV) Test
- Aug 02, 2023: Inflammation Marker Signifies Increased Mortality Risk, Finds New Study In PLOS ONE
- Jul 31, 2023: Quest Introduces First-To-Market Consumer-Initiated Blood Test for Alzheimer's Disease Risk Assessment on questhealth.com
- Jul 13, 2023: Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Quest Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Quest Diagnostics Inc Pipeline Products by Equipment Type
- Quest Diagnostics Inc Pipeline Products by Indication
- Quest Diagnostics Inc, Key Facts
- Quest Diagnostics Inc, Major Products and Services
- Quest Diagnostics Inc Number of Pipeline Products by Development Stage
- Quest Diagnostics Inc Pipeline Products Summary by Development Stage
- AAVrh74 ELISA Companion Diagnostic Assay - Duchenne Muscular Dystrophy (DMD) - Product Status
- AAVrh74 ELISA Companion Diagnostic Assay - Duchenne Muscular Dystrophy (DMD) - Product Description
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD) - Product Status
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD) - Product Description
- AI-Enabled Computational Pathology - Solid Tumor - Product Status
- AI-Enabled Computational Pathology - Solid Tumor - Product Description
- Biomarker Test - Genetic Disorders - Product Status
- Biomarker Test - Genetic Disorders - Product Description
- Bromotyrosine Test - Product Status
- Bromotyrosine Test - Product Description
- Cardio IQ KIF6 Genotype Test - Product Status
- Cardio IQ KIF6 Genotype Test - Product Description
- Cardiovascular Mortality Prediction Test - Product Status
- Cardiovascular Mortality Prediction Test - Product Description
- Diagnostic Assay - Colorectal Cancer - Product Status
- Diagnostic Assay - Colorectal Cancer - Product Description
- Genotyping Assay - Cystic Fibrosis - Product Status
- Genotyping Assay - Cystic Fibrosis - Product Description
- Genotyping Assay - Fragile X Syndrome - Product Status
- Genotyping Assay - Fragile X Syndrome - Product Description
- HDL Function Test - Product Status
- HDL Function Test - Product Description
- LungDx - Product Status
- LungDx - Product Description
- MRD Test - Breast Cancer - Product Status
- MRD Test - Breast Cancer - Product Description
- MRD Test - Colorectal Cancer - Product Status
- MRD Test - Colorectal Cancer - Product Description
- MRD Test - Lung Cancer - Product Status
- MRD Test - Lung Cancer - Product Description
- Urine Biomarker Test - Prostate Cancer - Product Status
- Urine Biomarker Test - Prostate Cancer - Product Description
- VeraMarker BCR Test - LDT - Product Status
- VeraMarker BCR Test - LDT - Product Description
- ViroSeq HCV Assay - Product Status
- ViroSeq HCV Assay - Product Description
- Quest Diagnostics Inc, Key Employees
- Quest Diagnostics Inc, Key Employee Biographies
- Quest Diagnostics Inc, Subsidiaries
- Quest Diagnostics Inc, Joint Venture
- Glossary
- Quest Diagnostics Inc Pipeline Products by Equipment Type
- Quest Diagnostics Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Novant Health Inc
- Nymox Pharmaceutical Corp
- Bio-Rad Laboratories Inc
- Laboratory Corp of America Holdings
- Net Medical Xpress Solutions Inc
- RadNet Inc
- Psychemedics Corp
- Celcuity Inc
- Thermo Fisher Scientific Inc
- Net Medical Xpress Solutions Inc
- Alere Inc
- Novant Health Inc
- Nymox Pharmaceutical Corp
- OpGen Inc
- Personalis Inc
- Celcuity Inc
- Thermo Fisher Scientific Inc
- Life Technologies Corp
- Psychemedics Corp
- Alere Inc
- Personalis Inc
- OpGen Inc
- RadNet Inc
- Laboratory Corp of America Holdings
- Bio-Rad Laboratories Inc
- Life Technologies Corp
